| scholarly article | Q13442814 |
| P50 | author | Brigitte Sola | Q42638665 |
| Olivier Hérault | Q60142572 | ||
| Fabrice Gouilleux | Q84216569 | ||
| P2093 | author name string | Simon Body | |
| Jérôme Bourgeais | |||
| Sophie Bustany | |||
| Guergana Tchakarska | |||
| P2860 | cites work | Cyclin D1 interacts and collaborates with Ral GTPases enhancing cell detachment and motility | Q24337518 |
| PACSIN 2 represses cellular migration through direct association with cyclin D1 but not its alternate splice form cyclin D1b | Q24610494 | ||
| Molecular pathogenesis of multiple myeloma: basic and clinical updates | Q27026205 | ||
| The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology | Q27860991 | ||
| Cyclin D as a therapeutic target in cancer | Q28242623 | ||
| Cyclin D1 functions in cell migration | Q28274139 | ||
| Targeting MUC1-C is synergistic with bortezomib in downregulating TIGAR and inducing ROS-mediated myeloma cell death | Q33585280 | ||
| Mitochondrial thioredoxin reductase regulates major cytotoxicity pathways of proteasome inhibitors in multiple myeloma cells. | Q33701777 | ||
| NADPH oxidases regulate cell growth and migration in myeloid cells transformed by oncogenic tyrosine kinases | Q33834313 | ||
| New Strategies in the Treatment of Multiple Myeloma | Q33958520 | ||
| G1 cell-cycle control and cancer | Q34368858 | ||
| The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma | Q34448863 | ||
| Cyclin D1 determines mitochondrial function in vivo | Q35070938 | ||
| Cyclin D1 governs adhesion and motility of macrophages | Q35153599 | ||
| Synergistic Activity of Carfilzomib and Panobinostat in Multiple Myeloma Cells via Modulation of ROS Generation and ERK1/2. | Q35592352 | ||
| Cyclin D1 sensitizes myeloma cells to endoplasmic reticulum stress-mediated apoptosis by activating the unfolded protein response pathway | Q35604566 | ||
| Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma | Q35847805 | ||
| Redox regulation of cell migration and adhesion | Q35889032 | ||
| Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma | Q36384889 | ||
| Senescence-associated secretory phenotype favors the emergence of cancer stem-like cells. | Q36525196 | ||
| Redox regulation and its emerging roles in stem cells and stem-like cancer cells | Q37322470 | ||
| Pathogenesis of Myeloma | Q37831905 | ||
| Manipulation of cellular redox parameters for improving therapeutic responses in B‐cell lymphoma and multiple myeloma | Q37940343 | ||
| MEK inhibitors as a chemotherapeutic intervention in multiple myeloma | Q38092584 | ||
| Therapeutic advancements in multiple myeloma | Q38252583 | ||
| Targeting the bone marrow microenvironment in multiple myeloma. | Q38289041 | ||
| Cell adhesion-mediated drug resistance (CAM-DR) is associated with activation of NF-κB (RelB/p50) in myeloma cells | Q38355225 | ||
| Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma | Q38878577 | ||
| Adhesion to fibronectin induces p27(Kip1) nuclear accumulation through down-regulation of Jab1 and contributes to cell adhesion-mediated drug resistance (CAM-DR) in RPMI 8,226 cells | Q39068932 | ||
| Sorafenib inhibits cell migration and stroma-mediated bortezomib resistance by interfering B-cell receptor signaling and protein translation in mantle cell lymphoma | Q39227871 | ||
| Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules | Q39239701 | ||
| Antibody-induced nonapoptotic cell death in human lymphoma and leukemia cells is mediated through a novel reactive oxygen species-dependent pathway | Q39392738 | ||
| Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion | Q39562168 | ||
| Cyclin D1 Inhibits Mitochondrial Activity in B Cells | Q39587826 | ||
| Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells | Q39736048 | ||
| Bortezomib overcomes cell-adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma | Q39930099 | ||
| Alternate cyclin D1 mRNA splicing modulates p27KIP1 binding and cell migration | Q40027619 | ||
| Cyclin D1 induction of cellular migration requires p27(KIP1). | Q40218988 | ||
| Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors | Q40550020 | ||
| Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines | Q41328166 | ||
| Cyclin D1 localizes in the cytoplasm of keratinocytes during skin differentiation and regulates cell–matrix adhesion | Q42866996 | ||
| Redox homeostasis modulates the sensitivity of myeloma cells to bortezomib | Q43806000 | ||
| PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH/ROS balance | Q46868792 | ||
| Adhesion to fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR). | Q52540929 | ||
| Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation. | Q54775097 | ||
| Occurrence of cytochrome b558 in B-cell lineage of human lymphocytes | Q68446886 | ||
| Parthenolide-induced apoptosis in multiple myeloma cells involves reactive oxygen species generation and cell sensitivity depends on catalase activity | Q79273390 | ||
| P433 | issue | 29 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | drug resistance | Q12147416 |
| cell adhesion | Q187640 | ||
| cell migration | Q189092 | ||
| P304 | page(s) | 45214-45224 | |
| P577 | publication date | 2016-07-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Cyclin D1 unbalances the redox status controlling cell adhesion, migration, and drug resistance in myeloma cells | |
| P478 | volume | 7 |
| Q97692648 | Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells |
| Q50330020 | Endoplasmic reticulum stress in the development of multiple myeloma and drug resistance |
| Q50287987 | In vitro and in vivo cytotoxic effect of AntiGan against tumor cells |
| Q39185604 | Mechanisms of Resistance in Multiple Myeloma |
| Q55091606 | Soluble and Cell-Cell-Mediated Drivers of Proteasome Inhibitor Resistance in Multiple Myeloma. |
| Q59797793 | Targeted Therapy-Resistant Melanoma Cells Acquire Transcriptomic Similarities with Human Melanoblasts |
| Q49732981 | Transcription activated p73-modulated cyclin D1 expression leads to doxorubicin resistance in gastric cancer |
Search more.